drugset / Trial / NCT01463202
Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
RandomizedSingle-groupOpen-labelTreatment
Summary
The investigators plan to enroll 184 women who are planning to breastfeed and use DMPA after delivery to find out whether the timing of postpartum administration of DMPA (prior to hospital discharge or 4-6 weeks after delivery) affects the duration or exclusivity of breastfeeding among women who plan to breastfeed their infants.
Timeline
- Start
- 2011-11
- Primary completion
- 2017-02-13
- Completion
- 2017-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | medroxyprogesterone acetate | Other / unclassified | — | — |